country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-182435

Copy Link Print Information

CLE-030

CLE-030 is a KCNQ2 agonist with non-gating-dependent current-modulating activity. CLE-030 modulates neuronal network activity. CLE-030 can be used in studies related to pain, epilepsy and benign familial neonatal convulsions.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 2803111-66-0
分子式: C₂₀H₂₀Br₂N₄OS₂
分子量:556.34

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

CLE-030 構造式

CAS 番号: 2803111-66-0

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

体外実験

CLE-030 (Compound 34) (10 μM; for at least 3 min) increases channel currents in CHO-K1 cells transfected with human KCNQ2^[1].
CLE-030 (0.1-10 μM) potently activates wild-type human KCNQ2 channels expressed in CHO cells, with an EC₅₀ of 3.9 μM. It enhances channel currents without altering voltage sensitivity or gating kinetics^[2].
CLE-030 (0.1-10 μM) shows significantly reduced activation potency toward W236A, L299A, and V302A mutant KCNQ2 channels expressed in CHO cells^[2].
CLE-030 (0.1-10 μM) selectively activates human KCNQ2, KCNQ4 and KCNQ5 channels expressed in CHO cells, and exhibits no significant activity against KCNQ1, KCNQ3^A315T, BK_Ca, Kv1.2, Kir4.1 or TREK-1 channels^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

化学情報

CAS 番号 2803111-66-0
分子量 556.34
分子式 C₂₀H₂₀Br₂N₄OS₂
SMILES

O=C(CSC1=NN=C(CSCC2=CC=C(C)C=C2)N1C)NC3=CC=C(C=C3Br)Br
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Yang Huaiyu, et al. Triazole derivative and preparation method and application thereof. CN116763781A. 2023-09-19.

[2]. Liu S, et al. General Pharmacological Activation Mechanism of K⁺ Channels Bypassing Channel Gates. J Med Chem. 2022;65(15):10285-10299. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ